July 17, 2025

FDA Approves Shingrix Prefilled Syringe Option

The FDA has approved a new prefilled syringe presentation of Shingrix to simplify herpes zoster vaccination for eligible adult patients.

Conexiant

July 17, 2025

Nirsevimab Shows 83% Efficacy Over 6 Months

A large clinical trial in Europe showed that a single dose of nirsevimab reduced infant hospitalizations for RSV-associated lower respiratory tract infections by over 80% over a six-month period.

Conexiant

July 17, 2025

Metformin Ineffective for COVID Recovery, Trial Finds

Researchers found metformin did not significantly shorten COVID-19 symptom duration in low-risk outpatients, though it was safe and well tolerated.

Conexiant

July 17, 2025

Cancer History Linked to Severe COVID-19, Study 

Adult childhood cancer survivors had a higher risk of severe COVID-19 despite lower infection rates and higher vaccination coverage.

Conexiant

July 16, 2025

Pandemic-Era Dog Acquisition Linked to Later Well-Being Decline

In a small sample, dog acquisition during the COVID-19 pandemic was linked to a brief rise in cheerfulness, followed by potential declines in well-being, with effects varying by caregiving role and measure.

Conexiant

July 14, 2025

Pegivirus in Brain Linked to Parkinson’s Disease

A new study identified human pegivirus in the brains and blood of patients with Parkinson’s disease, revealing virus-linked immune and gene expression changes that varied by genetic background.

Conexiant

July 10, 2025

1 in 4 U.S. Infants Missing Bifidobacterium: Study

Babies who lacked this key gut bacteria were at an increased risk of eczema, allergies, and asthma by age 2.

Conexiant

July 09, 2025

West Nile Virus: Key Clinical Updates

West Nile virus remains the top mosquito-borne illness in the U.S., with high neuroinvasive disease and mortality rates, especially in transplant recipients, according to a new JAMA review.

Conexiant

July 09, 2025

Recombinant Zoster Vaccine Linked to New-Onset Lupus

Researchers report the first documented case of systemic lupus erythematosus following Shingrix vaccination.

Conexiant